ANA 2018 Annual Meeting: Preview of a Landmark Year

Last year in San Diego, ANA Annual Meeting attendees were abuzz over the plenary on breakthrough therapies with antisense oligonucleotides. Seeing video of children with spinal muscular atrophy up and out of wheelchairs was nothing short of exhilarating. What will generate the most excitement this October in Atlanta? The latest advances in viral vectors for delivery of gene therapy? Advances in cell-based therapies?

M. Elizabeth Ross, MD, PhD, Chair of the ANA Scientific Program Advisory Committee (SPAC) and Director of the Center for Neurogenetics at Weill Cornell Medicine, offers her perspective: Preview of a Landmark Year